Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry.
Fernandez-Sojo J, Horton R, Cid J, Azqueta C, Garcia-Buendia A, Valdivia E, Martorell L, Rubio-Lopez N, Codinach M, Aran G, Marsal J, Mussetti A, Martino R, Diaz-de-Heredia C, Ferra C, Valcarcel D, Linares M, Ancochea A, García-Rey E, García-Muñoz N, Medina L, Carreras E, Villa J, Lozano M, Gibson D, Querol S. Fernandez-Sojo J, et al. Among authors: valcarcel d. Bone Marrow Transplant. 2022 Oct;57(10):1531-1538. doi: 10.1038/s41409-022-01750-2. Epub 2022 Jul 8. Bone Marrow Transplant. 2022. PMID: 35804055 Free PMC article.
Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study.
Valcárcel D, Sanz MA Jr, Sureda A, Sala M, Muñoz L, Subirá M, Laborda R, Clopés A, Sierra J. Valcárcel D, et al. Bone Marrow Transplant. 2002 May;29(9):783-7. doi: 10.1038/sj.bmt.1703543. Bone Marrow Transplant. 2002. PMID: 12040477 Clinical Trial.
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
Pérez-Simón JA, Díez-Campelo M, Martino R, Brunet S, Urbano A, Caballero MD, de León A, Valcárcel D, Carreras E, del Cañizo MC, López-Fidalgo J, Sierra J, San Miguel JF. Pérez-Simón JA, et al. Among authors: valcarcel d. Br J Haematol. 2005 Aug;130(3):394-403. doi: 10.1111/j.1365-2141.2005.05614.x. Br J Haematol. 2005. PMID: 16042689 Free article.
Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission.
Martino R, Valcárcel D, Brunet S, Sureda A, Sierra J. Martino R, et al. Among authors: valcarcel d. Bone Marrow Transplant. 2008 Jan;41(1):33-8. doi: 10.1038/sj.bmt.1705879. Epub 2007 Nov 5. Bone Marrow Transplant. 2008. PMID: 17982504
Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vazquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Perez-Simón JA, Sierra J. Valcárcel D, et al. J Clin Oncol. 2008 Feb 1;26(4):577-84. doi: 10.1200/JCO.2007.11.1641. Epub 2007 Dec 17. J Clin Oncol. 2008. PMID: 18086801
174 results